The FDA’s peptide circus is underway. An advisory panel, stacked with RFK Jr.’s pro-peptide appointees, has voted to add BPC-157 and KPV to the bulk compounding list. This is despite FDA staff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results